comparemela.com

Latest Breaking News On - Cardiovascular porrtfolio - Page 1 : comparemela.com

Oversea Chinese Banking CORP Ltd Makes New Investment in Medtronic plc (NYSE:MDT)

Oversea Chinese Banking CORP Ltd bought a new position in shares of Medtronic plc (NYSE:MDT – Get Rating) in the 4th quarter, HoldingsChannel reports. The fund bought 55,579 shares of the medical technology company’s stock, valued at approximately $4,320,000. Other hedge funds also recently bought and sold shares of the company. Syverson Strege & Co […]

Medtronic plc (NYSE:MDT) Stake Reduced by North Star Asset Management Inc

North Star Asset Management Inc. lessened its holdings in shares of Medtronic plc (NYSE:MDT – Get Rating) by 2.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,884 shares of the medical technology company’s stock after selling 125 shares during the quarter. North Star Asset Management Inc.’s […]

Forefront Analytics LLC Invests $279,000 in Medtronic plc (NYSE:MDT)

Forefront Analytics LLC bought a new position in shares of Medtronic plc (NYSE:MDT – Get Rating) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 3,589 shares of the medical technology company’s stock, valued at approximately $279,000. A number of other institutional investors have also […]

Kingsview Wealth Management LLC Boosts Holdings in Medtronic plc (NYSE:MDT)

Kingsview Wealth Management LLC raised its holdings in shares of Medtronic plc (NYSE:MDT – Get Rating) by 8.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 61,151 shares of the medical technology company’s stock after purchasing an additional 4,854 shares during the period. Kingsview Wealth Management LLC’s holdings in Medtronic were worth $4,753,000 at […]

Medtronic (NYSE:MDT) Raised to Overweight at Morgan Stanley

Morgan Stanley upgraded shares of Medtronic (NYSE:MDT – Get Rating) from an equal weight rating to an overweight rating in a research note released on Tuesday, Marketbeat reports. Morgan Stanley currently has $104.00 target price on the medical technology company’s stock. A number of other equities analysts have also recently weighed in on the company. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.